hGHRL

Nomenclature

C57BL/6JSmo-Ghrltm1(hGHRL)Smoc

Cat. NO.

NM-HU-242368

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Ghrl

Model Description

The endogenous mouse Ghrl gene was replaced by human GHRL gene.

Validation Data

image.png

Fig.1 Detection of GHRL expression in stomach by RT-PCR. Mouse Ghrl mRNA (108 bp) was detectable only in wild-type C57BL/6 mice. Human GHRL mRNA (123 bp) was detectable only in homozygous hGHRL knockin mice but not in wild-type mice. Stomach RNA was extracted from 10-week-old female wild-type C57BL/6 (WT, n=3) and homozygous hGHRL knockin mice (HO, n=3), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.2 Detection of human Obestatin expression in serum of WT C57BL/6 mice and HO hGHRL mice by ELISA. Obestatin was detectable in serum from both WT C57BL/6 and homozygous hGHRL knockin mice, as the ELISA kit was cross-reactived between human and mouse Obestatin. Serum were collected from wild-type C57BL/6 mice (n=3, female, 10 weeks old) and HO hGHRL knockin mice (n=3, female, 10 weeks old), and analyzed by ELISA. 

Abbr.  HO, homozygous; WT, wild type.

image.png

Fig.3 Detection of human Ghrelin expression in serum of WT C57BL/6 mice and HO hGHRL mice by ELISA. Ghrelin was detectable in serum from both WT C57BL/6 and homozygous hGHRL mice, as the ELISA kit was cross-reactived between human and mouse Ghrelin. Serum were collected from wild-type C57BL/6 mice (n=2, female, 10 weeks old) and HO hGHRL knockin mice (n=2, female, 10 weeks old), and analyzed by ELISA. 

Abbr. HO, homozygous; WT, wild type.

image.png

Fig.4 Body weight of WT C57BL/6 mice (6 females, 7.7 weeks old; 12 males, 6.7-7.7 weeks old) and HO hGHRL mice (5 females, 7 weeks old; 11 males, 6.3-7 weeks old). The body weight of homozygous hGHRL mice was slightly higher than WT mice. 

Abbr.  HO, homozygous; WT, wild type.




You may also like

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more